Related Experiment Videos
Comparison of conformational analysis techniques to generate pharmacophore hypotheses using catalyst
Rajendra Kristam1, Valerie J Gillet, Richard A Lewis
1Department of Information Studies, University of Sheffield, Regent Court, 211 Portobello Street, Sheffield S1 4DP, U.K.
Journal of Chemical Information and Modeling
|April 6, 2005
Summary
Generating reliable pharmacophore models for drug design is crucial. Faster rule-based conformational analysis methods yield pharmacophore models comparable or superior to slower, rigorous approaches.
Area of Science:
- Computational Chemistry
- Drug Discovery
- Medicinal Chemistry
Background:
- Pharmacophore models are essential for rational drug design.
- The quality of conformer sets significantly impacts pharmacophore model reliability.
- Evaluating different conformational analysis methods is key to optimizing pharmacophore generation.
Purpose of the Study:
- To compare the efficacy of various conformational analysis methods for pharmacophore generation using Catalyst/HypoGen.
- To determine if faster methods can produce pharmacophore models of comparable or superior quality to slower, more rigorous methods.
Main Methods:
- Selected five conformational analysis methods: Catalyst/Fast, Catalyst/Best, Omega, Chem-X, and MacroModel.
- Utilized datasets with previously published Catalyst models and defined quality measures.
- Generated pharmacophore hypotheses and compared method performance using quantitative (cost, correlation coefficients) and qualitative (feature presence, spatial relationships) metrics.
Main Results:
- Replication of literature results was not always successful; reasons are explored.
- Faster, rule-based conformational analysis methods (e.g., Catalyst/Fast) produced pharmacophore models of comparable quality.
- In some cases, faster methods yielded superior pharmacophore models compared to slower, rigorous approaches.
Conclusions:
- The choice of conformational analysis method significantly influences pharmacophore model quality.
- Faster, rule-based methods are viable and potentially advantageous alternatives for generating high-quality pharmacophore models in drug design.
- Standardized reporting templates are proposed for studies employing the Catalyst methodology to ensure reproducibility.